Fate Therapeutics Inc
Ownership
Ownership Structure
Who owns Fate Therapeutics Inc (FATE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 87.8% of the shares are freely tradable; institutional investors hold 72.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Redmile Group, LLC | 10.74 | 12,872,946 | +0.0 | 06/30/2026 |
| BlackRock Inc | 8.40 | 10,068,614 | -1.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.50 | 4,192,063 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 3.45 | 4,134,585 | +0.0 | 03/31/2026 |
| Acadian Asset Management LLC | 3.44 | 4,120,200 | +44,203.2 | 03/31/2026 |
| Two Sigma Investments LLC | 3.00 | 3,589,863 | +3.6 | 06/30/2026 |
| Johnson & Johnson | 2.82 | 3,379,064 | +0.0 | 06/30/2026 |
| AQR Capital Management LLC | 2.51 | 3,001,521 | +158.3 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.67 | 3,194,411 | +0.0 | 07/31/2026 |
| Vanguard Strategic Equity Inv | 2.61 | 3,124,076 | +23.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Valamehr Bahram | President and CEO | 591,815 | 1,479,538 $ | Aug 4, 2026 | direct |
| Tahl Cindy | See Remarks | 589,355 | 1,473,388 $ | Aug 4, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Tahl Cindy | See Remarks | Sell | 38,800 | 2.46 | 95,405 |
| Aug 4, 2026 | Valamehr Bahram | President and CEO | Sell | 43,947 | 2.46 | 108,101 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.